Moderate To Severe Vasomotor Symptoms Vms clinical trials

Explore recruiting moderate to severe vasomotor symptoms vms clinical trials.

Recruiting moderate to severe vasomotor symptoms vms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Moderate To Severe Vasomotor Symptoms Vms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Placebo-controlled, Double-blind, Phase 3 Clinical Study to Investigate the Efficacy and Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms (Hot Flashes) in Women with Stage 0 to 3 Hormone Receptor-positive Breast Cancer Who Are Receiving Adjuvant Endocrine Therapy

Hungary, Denmark, Italy, Czechia, Germany, France +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Moderate To Severe Vasomotor Symptoms Vms trials by city

Moderate To Severe Vasomotor Symptoms Vms in Toronto Moderate To Severe Vasomotor Symptoms Vms in Vancouver Moderate To Severe Vasomotor Symptoms Vms in Montreal Moderate To Severe Vasomotor Symptoms Vms in Calgary Moderate To Severe Vasomotor Symptoms Vms in Edmonton Moderate To Severe Vasomotor Symptoms Vms in Ottawa Moderate To Severe Vasomotor Symptoms Vms in Winnipeg Moderate To Severe Vasomotor Symptoms Vms in Quebec City Moderate To Severe Vasomotor Symptoms Vms in Hamilton Moderate To Severe Vasomotor Symptoms Vms in Kitchener Moderate To Severe Vasomotor Symptoms Vms in London Moderate To Severe Vasomotor Symptoms Vms in Halifax Moderate To Severe Vasomotor Symptoms Vms in New York Moderate To Severe Vasomotor Symptoms Vms in Los Angeles Moderate To Severe Vasomotor Symptoms Vms in Chicago Moderate To Severe Vasomotor Symptoms Vms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease